- Home
- REAL vs MANE Comparison
REAL vs MANE Comparison
Compare REAL & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REAL | MANE |
|---|---|---|
| Founded | 2011 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | REAL | MANE |
|---|---|---|
| Price | $11.69 | $101.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | $17.00 | ★ $83.33 |
| AVG Volume (30 Days) | ★ 2.4M | 619.3K |
| Earning Date | 05-07-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.55 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $692,845,000.00 | N/A |
| Revenue This Year | $14.30 | N/A |
| Revenue Next Year | $10.15 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.38 | N/A |
| 52 Week Low | $4.71 | $36.26 |
| 52 Week High | $17.39 | $114.50 |
Technical Indicators
Market Signals| Indicator | REAL | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 56.37 | 70.04 |
| Support Level | $10.52 | $54.23 |
| Resistance Level | $12.87 | N/A |
| Average True Range (ATR) | 0.67 | 9.46 |
| MACD | 0.06 | 2.78 |
| Stochastic Oscillator | 52.14 | 73.59 |
Price Performance
Historical ComparisonAbout REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.